107 related articles for article (PubMed ID: 6950412)
1. Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin.
Sher JH; Stracher A; Shafiq SA; Hardy-Stashin J
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7742-4. PubMed ID: 6950412
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic trials in muscular dystrophy. III. Studies of microbial proteinase inhibitors in murine dystrophy.
Enomoto A; Bradley WG
Arch Neurol; 1977 Dec; 34(12):771-3. PubMed ID: 337944
[TBL] [Abstract][Full Text] [Related]
3. Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors.
Stracher A; McGowan EB; Shafiq SA
Science; 1978 Apr; 200(4337):50-1. PubMed ID: 635570
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic trial with protease inhibitor (leupeptin) in chicken muscular dystrophy. A histologic and histochemical study.
Nonaka I; Ishiura S; Takagi A; Sugita H
Acta Neuropathol; 1982; 58(4):279-85. PubMed ID: 7158305
[TBL] [Abstract][Full Text] [Related]
5. Proteinase inhibitors and muscle degeneration.
Stracher A
Muscle Nerve; 1982; 5(6):494. PubMed ID: 7133046
[No Abstract] [Full Text] [Related]
6. Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain.
McGowan EB; Shafiq SA; Stracher A
Exp Neurol; 1976 Mar; 50(3):649-57. PubMed ID: 1253868
[No Abstract] [Full Text] [Related]
7. Treatment of mouse muscular dystrophy with the protease inhibitor pepstatin.
Schorr EE; Arnason BG; Aström KE; Darzynkiewicz Z
J Neuropathol Exp Neurol; 1978 May; 37(3):263-8. PubMed ID: 660216
[TBL] [Abstract][Full Text] [Related]
8. Antiproteinase chemotherapy of acute experimental pancreatitis using the low molecular weight oligopeptide aldehyde leupeptin.
Jones PA; Hermon-Taylor J; Grant DA
Gut; 1982 Nov; 23(11):939-43. PubMed ID: 6182054
[TBL] [Abstract][Full Text] [Related]
9. Chymostatin has no apparent beneficial effect on muscular dystrophy in the mdx mouse.
Christie KN
J Neurol Sci; 1988 Apr; 84(2-3):341-6. PubMed ID: 3379449
[TBL] [Abstract][Full Text] [Related]
10. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.
Foltz SJ; Luan J; Call JA; Patel A; Peissig KB; Fortunato MJ; Beedle AM
Skelet Muscle; 2016; 6():20. PubMed ID: 27257474
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
Körner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M
Am J Pathol; 2014 May; 184(5):1518-28. PubMed ID: 24631023
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of murine muscular dystrophy with the protease inhibitor bestatin.
Tsuji S; Matsushita H
J Neurol Sci; 1986 Feb; 72(2-3):183-94. PubMed ID: 3711932
[TBL] [Abstract][Full Text] [Related]
13. Calpain inhibitors as therapeutic agents in nerve and muscle degeneration.
Stracher A
Ann N Y Acad Sci; 1999 Nov; 884():52-9. PubMed ID: 10842583
[TBL] [Abstract][Full Text] [Related]
14. Limited benefit to genetically dystrophic chickens from a synthetic proteinase inhibitor: Ep475.
Hudecki MS; Pollina CM; Heffner RR
J Neurol Sci; 1983 Jul; 60(1):55-66. PubMed ID: 6875613
[TBL] [Abstract][Full Text] [Related]
15. Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
Körner Z; Durbeej M
PLoS One; 2016; 11(1):e0146471. PubMed ID: 26731667
[TBL] [Abstract][Full Text] [Related]
16. Retardation of symptoms of dystrophy in genetically dystrophic chickens by chemotherapy.
Hudecki MS; Barnard EA
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):167-76. PubMed ID: 935649
[TBL] [Abstract][Full Text] [Related]
17. Influence of spider Latrodectus tredecimguttatus poison on progressive muscular dystrophy in rat.
Stern P; Valjevac K; Gmaz-Nikulin E
Arzneimittelforschung; 1975 May; 25(5):769-71. PubMed ID: 1242318
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.
Carmignac V; Quéré R; Durbeej M
Hum Mol Genet; 2011 Feb; 20(3):541-52. PubMed ID: 21084425
[TBL] [Abstract][Full Text] [Related]
19. Animal models of muscle diseases, Part III: Compilation of therapeutic trials for hereditary muscular dystrophy.
Cosmos E; Butler J
Muscle Nerve; 1980; 3(5):427-35. PubMed ID: 7421876
[No Abstract] [Full Text] [Related]
20. Therapeutic trials in muscular dystrophy. 1. Gold in murine dystrophy.
Enomoto A; Bradley WG
J Neurol Neurosurg Psychiatry; 1978 May; 41(5):404-7. PubMed ID: 96218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
